FDA Inspection
Bolger & O'Hearn IncBolger & O'Hearn Inc – FDA Inspection, Dec 19, 2023
Record Details
This FDA Inspection record concerns Bolger & O'Hearn Inc, with an inspection on December 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d6dfe485-981d-43a4-b732-9d35b12a8e61
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1225549
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
18- 21 CFR 211.160(b)(3)Acceptance of drug products
- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.186(b)(8)Description of containers, labels, et. al.
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
- 21 CFR 211.101(a)Batches Formulated to less than 100%
- 21 CFR 211.101(a)Batches Formulated to less than 100%
Showing 10 of 18 citations.
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.